期刊
TRENDS IN BIOCHEMICAL SCIENCES
卷 39, 期 12, 页码 603-611出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2014.09.004
关键词
phospholipase C; disease-linked mutations; immune disorders; cancer; deregulation of signaling
资金
- Cancer Research UK
- Wellcome Trust
- Cancer Research UK [16567] Funding Source: researchfish
The surge in genetic and genomic investigations over the past 5 years has resulted in many discoveries of causative variants relevant to disease pathophysiology. Although phospholipase C (PLC) enzymes have long been recognized as important components in intracellular signal transmission, it is only recently that this approach highlighted their role in disease development through gain-of-function mutations. In this review we describe the new findings that link the PLC gamma family to immune disorders and cancer, and illustrate further efforts to elucidate the molecular mechanisms that underpin their dysfunction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据